-
Current through October 23, 2012
(a)(1) There is established, as a nonlapsing fund in the Department of Health, the Board of Pharmacy Fund ("Fund"), to be administered by the Mayor as an agency fund, as defined in § 47-373(2)(I), into which all licensing fees, civil fines, and interest earned relating to the practice of pharmaceutical detailing, and any other funds, as directed by law, shall be deposited and used for the administration of the Board of Pharmacy.
(2) For the purposes of this subsection, the term "practice of pharmaceutical detailing" shall have the same meaning as provided in § 3-1201.02(11A).
(b) All funds deposited into the Fund shall not revert to the unrestricted fund balance of the General Fund of the District of Columbia at the end of a fiscal year, or at any other time, but shall be continually available to the Department of Health for the uses and purposes set forth in subsection (a) of this section, subject to authorization by Congress.
(Oct. 3, 2001, D.C. Law 14-28, § 4904b, as added Mar. 26, 2008, D.C. Law 17-131, § 103, 55 DCR 1659.)
HISTORICAL AND STATUTORY NOTES
Legislative History of Laws
Law 17-131, the "SafeRx Amendment Act of 2008", was introduced in Council and assigned Bill No. 17-364 which was referred to the Committee on Health. The Bill was adopted on first and second readings on December 11, 2007, and January 8, 2008, respectively. Signed by the Mayor on February 1, 2008, it was assigned Act No. 17-282 and transmitted to both Houses of Congress for its review. D.C. Law 17-131 became effective on March 26, 2008.
Delegation of Authority
Delegation of Authority pursuant to D.C. Law 17-131, the SafeRX Amendment Act of 2008, see Mayor's Order 2008-83, June 11, 2008 (55 DCR 9360).
